If your SHBG is consistently high , it should certainly be taken into consideration even with the new BMS guidelines, see p 3:
“In certain circumstances, SHBG levels may be helpful as additional supportive information: Where SHBG levels are high […] Conversely, when SHBG levels are very low.”
Unfortunately, the BMS statement is inconsistent and downright contradictory here (p1):
“Oral estrogens, especially conjugated estrogens, can reduce the effectiveness of testosterone by increasing sex hormone binding globulin levels. Switching women with HSDD from oral to transdermal estrogen can be beneficial as this can increase the proportion of circulating free testosterone”.
In short, in that sentence they’re saying to consider SHBG and free T, only to go on to say on p 2 to give preference to total levels and ignore free T (but only sometimes).
Of course the reality is complex and an ‘either/or’ approach unhelpful, as is obvious in the paper on which they’ve based the new guidelines, A Reappraisal of Testosterone’s Binding in Circulation: Physiological and Clinical Implications (the paper also includes a list of possible causes of high SHBG Floraljo). If it’s not freely available online the BMS will send you a copy.
The paper is yet another illustration of how incredibly complex the endocrine sytem is and that even the so-called experts still have a very rudimentary understanding of the interactions.
Re high SHBG, mine has always been high but increases even more when my serum estradiol goes up, despite my never having touched oral estrogens. So, again, it's complicated.